Elevar Therapeutics · 2 hours ago
Head of Commercial Development (Remote)
Elevar Therapeutics is a rapidly growing biotech company that is evolving from a clinical-stage to a fully integrated commercial-stage biopharma company. The Head of Commercial Development will be instrumental in developing and executing commercial strategies to support launch readiness and will work closely with various teams to optimize commercial capabilities and ensure business performance objectives are met.
BiotechnologyHealth CareMedicalPharmaceuticalProduct DesignTherapeutics
Responsibilities
Develop and own the commercial development strategy for near-commercial pipelines
Lead in building, activating, and optimizing commercial capabilities to support excellence in planning and execution of sales, marketing, market access, patient support, HUB services, 3PL and other functions
Lead in standing up business planning, forecasting, performance monitoring, reporting, and management capabilities that enable leadership to effectively manage the business and achieve goals and objectives
Identify, recommend, implement, and ensure that the sales function has the key enabling capabilities in place to achieve business performance objectives including - CRM/Dashboard, Reporting, Forecasting, Call Planning, and Incentive Compensation
Partner closely with Clinical, Regulatory, and CMC teams to integrate commercial perspectives into clinical development plans
Work with the Business Development team to identify, negotiate, and manage strategic partnerships and licensing deals
Partner with IT to ensure systems, databases, and applications are developed to meet the needs of the Sales Administration department
Partner with Supply Chain to ensure alignment with demand forecast, inventory expectations, and overall Ex-Factory shipment expectations
Assists in developing a world-class Commercial Training and Employee Development function to ensure a strong and compliant commercial launch while supporting the ongoing growth and development of the employee base
Qualification
Required
Minimally, a BA/BS; MBA or other advanced degree is preferred
15+ years of work experience in the pharma/biotech industry preferred
Start-up experience, and in particular experience in launching a new drug at a small-to-medium biopharma company is important
Strong commercial understanding including Go to Market strategies, field IC design and execution, sales and marketing KPIs and metrics; strong understanding of the sales processes
Experience working with customer segmentation, customer profiling methodologies, and understanding how they impact financial results
Understanding of the commercial aspects of Oncology Rare Disease, including brand management, sales planning, execution, market access, and regulatory environments
Exposed to new product launches/product management practices with a focus on sales force sizing, targeting, and segmentation
High exposure to US pharmaceutical market dynamics and competitive intelligence - knowing market trends in healthcare emerging business models and best practices
Strategic mindset with high degree of creativity and innovation in developing new approaches, processes, and methodologies to enhance commercial operations
Strong leadership skills, demonstrated project management ability, and a positive approach in managing staff, vendors, and project-related issues
Ability to demonstrate Elevar's core values by holding ourselves and each other accountable for the work we do, taking time to collaborate effectively while working remotely, making space for ingenuity in work and thought, and staying grounded in compassion
Preferred
MBA or other advanced degree
15+ years of work experience in the pharma/biotech industry
Benefits
Medical
Dental
Vision
Time off
A retirement plan
Other voluntary benefits for employees
Company
Elevar Therapeutics
Elevar Therapeutics specializes in clinical development of promising therapies for unmet medical needs in cancer.
Funding
Current Stage
Early StageTotal Funding
$20M2018-07-25Series Unknown· $20M
Recent News
Elevar Therapeutics
2025-12-03
Company data provided by crunchbase